Tech
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Read the full discussion on TechCrunch
This article was aggregated from TechCrunch. Click to join the conversation.
View on TechCrunch